Citadel Advisors’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-100
Closed -$9.72K 14621
2023
Q3
$9.72K Buy
+100
New +$10.4K ﹤0.01% 13110
2023
Q2
Sell
-100
Closed -$10.8K 14641
2023
Q1
$10.8K Hold
100
﹤0.01% 13509
2022
Q4
$10.9K Sell
100
-7,300
-99% -$765K ﹤0.01% 13601
2022
Q3
$719K Buy
+7,400
New +$779K ﹤0.01% 7699
2021
Q3
Sell
-3,600
Closed -$422K 14076
2021
Q2
$422K Buy
+3,600
New +$411K ﹤0.01% 10442
2019
Q1
Sell
-21,600
Closed -$1.49M 9480
2018
Q4
$1.49M Buy
+21,600
New +$1.64M ﹤0.01% 4646
2018
Q2
Sell
-3,000
Closed -$208K 8977
2018
Q1
$208K Buy
+3,000
New +$216K ﹤0.01% 7296

Other funds holding FXH

Citadel Advisors's FXH Position: Q2 2026 in Review

Citadel Advisors sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q2 2026, closing a stake of 4,582 shares — an estimated $503K sold.

Citadel Advisors first reported a position in FXH in Q1 2014 and held it in 45 quarters. The position peaked at $17.3M in Q3 2020. 252 funds tracked by Wall St. Rank hold FXH as of Q2 2026.

  • Citadel Advisors reported no remaining First Trust Health Care AlphaDEX Fund position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 4,582 First Trust Health Care AlphaDEX Fund shares in Q2 2026, an estimated $503K.
  • Citadel Advisors first reported a position in First Trust Health Care AlphaDEX Fund in Q1 2014 and held it in 45 quarters.
  • Citadel Advisors's First Trust Health Care AlphaDEX Fund position peaked at $17.3M in Q3 2020.
  • 252 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.